Tristar Wellness Solutions Inc. (TWSI)
- Previous Close
0.0000 - Open
0.0310 - Bid 0.0120 x --
- Ask 0.0900 x --
- Day's Range
0.0310 - 0.0310 - 52 Week Range
0.0021 - 0.1500 - Volume
5 - Avg. Volume
470 - Market Cap (intraday)
7.911M - Beta (5Y Monthly) 12.77
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
TriStar Wellness Solutions, Inc. develops, markets, and sells wound care products. The company also offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical applicator for delivering medicants and internal devices within the body without producing injury or damage. In addition, it develops over-the-counter itch suppression products; and develops, manufactures, and markets wound care and infection control medical devices. The company was formerly known as BioPack Environmental Solutions, Inc. and changed its name to TriStar Wellness Solutions, Inc. in January 2013. TriStar Wellness Solutions, Inc. was incorporated in 2000 and is based in Portland, Oregon. On January 15, 2016, TriStar Wellness Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Oregon.
www.tstarwellness.com35
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: TWSI
View MorePerformance Overview: TWSI
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TWSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TWSI
View MoreValuation Measures
Market Cap
7.91M
Enterprise Value
7.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-176.96%
Return on Assets (ttm)
-63.80%
Return on Equity (ttm)
--
Revenue (ttm)
4M
Net Income Avi to Common (ttm)
-7.07M
Diluted EPS (ttm)
-0.9000
Balance Sheet and Cash Flow
Total Cash (mrq)
336k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-961.12k